Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 26, 2023
Catawba Research, a clinical research organization announced changes to its executive leadership team. Catawba’s Founder, Zaidoon A. Al-Zubaidy, is transitioning his day-to-day leadership responsibilities to Dr. Andy Silverman. Al-Zubaidy will become...
read more
Thursday, October 31, 2019
CathVision ApS has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform.
read more
Monday, September 21, 2020
CATO SMS has acquired Wilmington, NC-based Array Biostatistics to expand its offering of specialized clinical research solutions.
read more
Research Triangle Park, N.C.-based CATO SMS and Bracknell, U.K.-headquartered Pharm-Olam, both providers of specialized clinical research services, announced today that they are merging to form a leading global biopharmaceutical services organization...
read more
Wednesday, September 08, 2021
CATO SMS, a global provider of specialised clinical research solutions, announced that it has appointed Richard Vesely, M.D. as vice president of regulatory strategy. He brings to CATO SMS nearly 30 years of European regulatory and clinical ...
read more
Monday, September 07, 2020
CATO SMS has unveiled its new brand, revealing an updated look and logo capturing the company’s offering following the merger of CATO Research, and Specialized Medical Services-oncology.
read more
Wednesday, October 24, 2018
CavoGene has licensed a novel investigational gene therapy for patients with neurodegenerative diseases.
read more
Monday, November 23, 2020
CCRM and MIP have signed a LOI to partner in the development of a biomanufacturing campus at MIP focused on regenerative medicine-based technologies and cell and gene therapies.
read more
CDI Labs Canada Inc., a provider of services for proteome-wide antibody profiling and target identification, announced the launch of its Technology Access Program for custom peptide libraries for serum antibody analysis services.
read more
Thursday, September 21, 2023
The Montreal-based CDMO C3i Center Inc is paving the way in the cell and gene therapy industry in North American and Canada as one of a few contract development and manufacturing organizations (CDMOs) to be producing in North America and for Europe. ...
read more
Spray drying and capsule filling service provider Micro-Sphere is investing €19 million into expanding its GMP manufacturing capabilities at its facility in Switzerland.
read more
The Wasdell Group has secured a new contract to supply medicines and dietary supplements directly to consumers from its Swindon, UK, site.
read more
Tuesday, February 18, 2014
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract
development and manufacturing organization (CDMO) specializing in small molecule APIs, has
announced the hire Alex Tretyakov, Ph.D. as its Director of Process Development.
read more
Thursday, November 08, 2012
Cedarburg Hauser Pharmaceuticals (CHP), an experienced contract development and manufacturing organization (CDMO), has announced the appointment of John K. Lynch, Ph.D. as its Chief Scientific Officer (CSO).
read more
CEL-SCI has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.
read more